Professor of Medicine, University of Chicago Medicine
Hematology
Dr. Wendy Stock, PHD
|
|
Give Review
Wendy Stock practices Hematology. She researched medicine at Rush Medical College. She over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Wendy Stock is a published MD. She has 57 publications published. The most current publication "Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL..." Dr. Wendy Stock, PHD accepts all Medicare patients.
Publications
- Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL...
- How I Treat: Acute Lymphoblastic Leukemia in Older Adolescents and Young Adults (AYAs).
- A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia.
- REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia.
- MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia.
- Geriatric assessment to predict survival in older allogeneic hematopoietic celltransplantation recipients.
- Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant.
- Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype.
- Phase II Study Of The Oral MEK Inhibitor Selumetinib In Advanced Acute Myeloid Leukemia (AML): A University Of Chicago Phase II Consortium Trial.
- Imatinib 800Â mg daily induces deeper molecular responses than imatinib 400Â mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed ...
- Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: Results from Cancer and Leukemia Group B 19808.
- A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469.
- A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.
- Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
- Expanded indications for allogeneic stem cell transplantation in patients with myeloid malignancies.
- The genomic landscape of hypodiploid acute lymphoblastic leukemia.
- Umbilical Cord Blood Transplantation Supported by Third-Party Donor Cells: Rationale, Results, and Applications.
- Influence of related donor age on outcomes after peripheral blood stem cell transplantation.
- Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802.
- Progress in the treatment of adults with acute lymphoblastic leukemia.
- Pediatric regimens for adult acute lymphoblastic leukemia.
- Adolescents and young adults with acute lymphoblastic leukemia.
- What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Canc...
- Approaches to treatment for acute lymphoblastic leukemia in adolescents and young adults.
- Current treatment options for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
- Controversies in treatment of AML: case-based discussion.
- Advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
- Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
- Burkitt lymphoma/leukemia: improving prognosis.
- T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors...
- Clinical trials in adult AML.
- Adult acute lymphoblastic leukemia: concepts and strategies.
- An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.
- BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants.
- Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease r...
- Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation.
- P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cance...
- High Dose Cytarabine and Mitoxantrone: An Effective Induction Regimen for High-Risk Acute Myeloid Leukemia (AML).
- Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples.
- A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia.
- Minimal residual disease: current status in leukemia.
- Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia.
- Assaying Bcr-Abl kinase activity and inhibition in whole cell extracts by phosphorylation of substrates immobilized on agarose beads.
- Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
- Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?
- Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high ...
- Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients ...
- Successful allogeneic transplantation of patients with suspected prior invasive mold infection.
- Looking toward the future: novel strategies based on molecular pathogenesis of acute lymphoblastic leukemia.
- Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.
- Preface: acute lymphoblastic leukemia--quo vadis?
- Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia.
- Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory n...
- Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremis...
- High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902.
- Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship.
Schools
SUNY At Stonybrook
University Of California At Berkeley
Procedures Preformed
- Cognitive Behavioral Therapy (CBT)
- Couples Therapy
- Marital Counseling
- Marital Therapy
- View All
Conditions Treated
- Behavioral Disorders
- Depression
- Post-Traumatic Stress Disorder (PTSD)
- Relationship Issues
- View All
Doctors Specialties
- Clinical Psychology
- Hematology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
University of Chicago -
Rush Medical College
Hospital
-
University of Chicago Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Steven L. Turman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul Moore, PHD |
|
|
Dr. Kenneth S. Benau, PHD |
|
|
Dr. Francine Segal, PHD
This Doctor is OpenDoctor Recommended.
|
|
|
Miriam Marsolais |